VivoSim Labs VIVS
NASDAQ VIVS
$0.16 -0.02 (-9.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Liabilities and Shareholders Equity (2011 - 2026)

Updated

VivoSim Labs' Liabilities and Shareholders Equity was $3.85 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 67.9% from $11.98 million a year earlier and down 47.9% from the prior quarter.

Analysis

VivoSim Labs (VIVS) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Liabilities and Shareholders Equity at VivoSim Labs came in at $7.39 million, down 49.6% from FY2025.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -28.6% (FY2021 to FY2026).
  • In earlier fiscal years, Liabilities and Shareholders Equity was $14.65 million in FY2025 (+130.7%), $6.35 million in FY2024 (-68.7%), $20.31 million in FY2023 (-39.0%) and $33.3 million in FY2022 (-16.6%).
  • The fiscal Q1 2027 figure marks the lowest quarterly Liabilities and Shareholders Equity since fiscal Q3 2025.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in four of the last eight quarters, with growth averaging 8.5%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q4 2025 (growth of 130.7%); the worst was fiscal Q4 2024 (a decline of 68.7%).
  • Per Business Quant data, VIVS's Liabilities and Shareholders Equity in the three fiscal quarters before Q1 2027 was $7.39 million (Q4 2026), $6.96 million (Q3 2026) and $9.69 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 45.99 Bn 37.69 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 18.34 Bn 16.40 Bn 201.64 Mn 2.06 Bn
3 Charles River Laboratories International 16.28 Bn 15.48 Bn 363.37 Mn 7.53 Bn
4 Icon 14.45 Bn 11.56 Bn 479.29 Mn 16.40 Bn
5 Fortrea Holdings 2.26 Bn 1.64 Bn 139.20 Mn 2.71 Bn
6 Ginkgo Bioworks Holdings 598.59 Mn -163.49 Mn 18.44 Mn 990.05 Mn
7 Evotec SE 545.17 Mn -1.07 Bn - 1.80 Bn
8 Champions Oncology 66.15 Mn 41.24 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 55.19 Mn 18.85 Mn 1.61 Mn 12.36 Mn
10 VivoSim Labs 837,265.99 -16.89 Mn - 3.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.85 Mn
Mar 31, 2026 7.39 Mn
Dec 31, 2025 6.96 Mn
Sep 30, 2025 9.69 Mn
Jun 30, 2025 11.98 Mn
Mar 31, 2025 14.65 Mn
Dec 31, 2024 3.84 Mn
Sep 30, 2024 6.75 Mn
Jun 30, 2024 9.47 Mn
Mar 31, 2024 6.35 Mn
Dec 31, 2023 8.88 Mn
Sep 30, 2023 11.16 Mn
Jun 30, 2023 14.76 Mn
Mar 31, 2023 20.31 Mn
Dec 31, 2022 25.08 Mn
Sep 30, 2022 27.91 Mn
Jun 30, 2022 30.55 Mn
Mar 31, 2022 33.30 Mn
Dec 31, 2021 35.10 Mn
Sep 30, 2021 35.88 Mn
API Access

VivoSim Labs Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VIVS&period=max&api_key=YOUR_API_KEY